Ambreen Ahmed
Psychiatry · Sullivan, MONPI 1376655746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,120 and has fallen 90.2% since, to $110 in 2023.
Across 163 payments — averaging $13.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$521
- Johnson & Johnson$306
- Sunovion Pharmaceuticals Inc.$283
- Neurocrine Biosciences, Inc.$230
- Alkermes, Inc.$199
- Teva Pharmaceuticals USA, Inc.$180
- plus $511 from 10 others
What the payments were for
- Food & beverage$2,230100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 43 | $521 |
| Johnson & Johnson | 29 | $306 |
| Sunovion Pharmaceuticals Inc. | 20 | $283 |
| Neurocrine Biosciences, Inc. | 18 | $230 |
| Alkermes, Inc. | 14 | $199 |
| Teva Pharmaceuticals USA, Inc. | 6 | $180 |
| Avanir Pharmaceuticals, Inc. | 5 | $82 |
| AbbVie | 4 | $69 |
| Indivior Inc. | 4 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $60 |
| Shire North American Group Inc | 4 | $60 |
| Ironshore Pharmaceuticals Inc. | 3 | $48 |
| Corium, LLC | 3 | $40 |
| Lundbeck LLC | 3 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Orexo US, Inc. | 1 | $24 |
How this compares
$2,230 in reported general payments places this provider in the 75th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Sullivan
- Gregory MattingleySaint Charles$4.7M
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- Brian BarashKansas City$856K
- Casey ProughLees Summit$615K
- George GrossbergSaint Louis$501K
- Shahid InsafBranson$416K
- Ahmed TaranissiMexico$343K
- Ravdeep KhanujaPoplar Bluff$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.